Ratings for Edwards Lifesciences (NYSE:EW) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 6 | 2 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 0 | 0 | 0 |
| 2M Ago | 1 | 3 | 1 | 0 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $91.56, a high estimate of $103.00, and a low estimate of $77.00. Observing a 10.15% increase, the current average has risen from the previous average price target of $83.12.
Investigating Analyst Ratings: An Elaborate Study
The standing of Edwards Lifesciences among...
Login or create a forever free account to read this news
Sign up/Log in